Myseum (MYSE) Financials

Myseum.AI’s latest statements show a company with meaningful short-term liquidity but continued operating losses and very limited revenue. In Q2 2026, revenue declined to $37,000 from $73,000 in Q1 2026 and $78,000 in the year-ago quarter. Operating expenses remained elevated at $2.15 million, producing a $2.15 million operating loss and a $3.05 million net loss.

• Liquidity improved during Q2 2026. Cash and equivalents increased to $1.87 million from $777,000 in Q1, while short-term investments rose to $2.06 million. Including $816,000 of long-term investments, the company held approximately $4.75 million in cash and investments at quarter-end.
• The balance sheet remains relatively lightly leveraged. Total liabilities were $916,656 against $4.37 million of equity. Current assets of $4.15 million were approximately 5.3 times current liabilities of $778,000, providing a substantial near-term liquidity cushion.
• Financing provided a significant cash benefit. Myseum reported $3.08 million of net cash from financing activities in Q2 2026, which more than offset its operating and investing cash outflows and helped produce a $1.10 million increase in cash during the quarter.
• Operating cash burn improved modestly on a sequential basis. Net cash used in operating activities was $1.51 million in Q2 2026 versus $1.25 million in Q1, although the absolute level of cash consumption remains high relative to revenue.
• Investment activity is a major driver of cash movements. The company purchased $2.05 million of investments and sold or matured $1.58 million during Q2. These transactions materially affect reported cash balances but do not represent recurring operating revenue or internally generated cash flow.
• Non-cash adjustments substantially reduced the difference between accounting losses and operating cash flow. Q2 included $1.52 million of non-cash adjustments, meaning the reported $3.05 million net loss did not translate directly into an equivalent cash outflow. Investors should review the nature and sustainability of these adjustments.
• Revenue has continued to deteriorate. Quarterly revenue fell from $175,000 in Q3 2023 and $151,000 in Q2 2024 to $37,000 in Q2 2026. Revenue also declined approximately 49% sequentially from Q1 2026, indicating that the company has not yet demonstrated meaningful commercial traction.
• Losses remain disproportionate to revenue. Q2 operating expenses of $2.15 million were more than 58,000 times reported revenue, resulting in a $2.15 million operating loss. The company also recorded $910,000 of net other expense, contributing to the $3.05 million quarterly net loss and a basic loss of $0.61 per share.
• Shareholder dilution is increasing. Weighted-average basic shares outstanding rose to 4.98 million in Q2 2026 from 4.28 million in Q1. Common stock on the balance sheet also increased by approximately $3.56 million, consistent with additional equity financing and potential dilution for existing shareholders.
• The current cash position may not support a prolonged period of losses. Using Q2 operating cash burn of approximately $1.51 million as a rough guide, the company’s cash and investments represent only several quarters of funding before additional financing or a material improvement in operations may be required. This estimate excludes changes in investment values, capital needs and future financing.